Income Taxes - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Income Tax Disclosure [Line Items] | ||
| U.S. federal statutory rates | 21.00% | 21.00% |
| Effective income tax rate | (137.70%) | 1.50% |
| Provision for (benefit from) income taxes | $ 1,250 | $ 299 |
| Net change in provision for income taxes | $ 1,000 | |
| U.S. | ||
| Income Tax Disclosure [Line Items] | ||
| Research and development expenditure, maximum amortize period | 5 years | |
| Foreign | ||
| Income Tax Disclosure [Line Items] | ||
| Research and development expenditure, maximum amortize period | 15 years | |
| X | ||||||||||
- Definition Change in income tax expense benefit. No definition available.
|
| X | ||||||||||
- Definition Income tax disclosure. No definition available.
|
| X | ||||||||||
- Definition Tax Cuts And Jobs Act Of 2017, Research And Development Expenditure, Maximum Amortize Period No definition available.
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|